Clinical trial

Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

NCT00497133 · University of Copenhagen, Other · Completed

Key facts

NCT number NCT00497133
Title Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes
Lead sponsor University of Copenhagen, Other
Collaborators Novo Nordisk A/S Industry The Danish Diabetes Association
Status Completed
Study type Observational
Conditions Type 2 Diabetes Mellitus
Enrollment 20
Start date Jul 1, 2007
Primary completion Mar 1, 2008
Completion Mar 1, 2008
First posted Jul 6, 2007
Last update posted Jun 4, 2008
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies